Iain Stuart A.'s most recent trade in Yarrow Bioscience Inc. was a trade of 15,405 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on July 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 23 Jul 2026 | 15,405 | 95,944 (0%) | 0% | 0.9 | 13,828 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 30 Jun 2026 | 2,370 | 111,349 (0%) | 0% | 0.7 | 1,542 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 31 Mar 2026 | 2,876 | 112,363 (0%) | 0% | 0.6 | 1,718 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 31 Dec 2025 | 2,448 | 115,239 (0%) | 0% | 0.6 | 1,420 | Common Stock |
| Yarrow Bioscience Inc | Stuart Iain A. | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 30 Sep 2025 | 2,453 | 117,687 (0%) | 0% | 0.3 | 822 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.65 per share. | 30 Jun 2025 | 2,453 | 120,140 (0%) | 0% | 1.6 | 4,047 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 31 Mar 2025 | 6,044 | 122,593 (0%) | 0% | 1.6 | 9,550 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 31 Dec 2024 | 4,857 | 128,637 (0%) | 0% | 3.4 | 16,271 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 30 Sep 2024 | 109 | 133,494 (0%) | 0% | 1.9 | 205 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 01 Jul 2024 | 138 | 133,603 (0%) | 0% | 1.9 | 265 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 01 Apr 2024 | 157 | 133,741 (0%) | 0% | 3.1 | 484 | Common Stock |
| Yarrow Bioscience Inc | Stuart A. Iain | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 134,055 (0%) | 0% | 0 | Common Stock | |
| Yarrow Bioscience Inc | Iain Stuart A. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Yarrow Bioscience Inc | Stuart A. Iain | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. | 01 Jan 2024 | 157 | 133,898 (0%) | 0% | 2.3 | 358 | Common Stock |
| Yarrow Bioscience Inc | Stuart A. Iain | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 71,555 (0%) | 0% | 0 | Common Stock | |
| Yarrow Bioscience Inc | Stuart Iain A. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 30 Jun 2023 | 151 | 10,239 (0%) | 0% | 4.1 | 619 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 31 Mar 2023 | 480 | 10,390 (0%) | 0% | 3.1 | 1,478 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 31 Dec 2022 | 1,720 | 220,252 (0%) | 0% | 0.2 | 258 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 30 Sep 2022 | 1,719 | 221,972 (0%) | 0% | 0.2 | 383 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 30 Jun 2022 | 1,719 | 223,691 (0%) | 0% | 0.4 | 669 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 31 Mar 2022 | 3,469 | 225,410 (0%) | 0% | 0.7 | 2,255 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 75,000 | - | - | Stock Options | |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 228,879 (0%) | 0% | 0 | Common Stock | |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 30 Sep 2021 | 1,480 | 155,129 (0%) | 0% | 1.4 | 2,057 | Common Stock |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,860 | 60,860 | - | - | Stock Options | |
| Yarrow Bioscience Inc | Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,859 | 156,609 (0%) | 0% | 0 | Common Stock |